We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Global Blood Gas Analyzers Market to Surpass USD 940 Million by 2026

By LabMedica International staff writers
Posted on 22 Jun 2019
The global blood gas analyzers market was valued at USD 594.6 million in 2017 and is projected to grow at a CAGR of 5.5% over the forecast period (2018 – 2026) to surpass USD 940 million by 2026. More...
The market growth is expected to be driven by the increasing global geriatric population across that is highly susceptible to various chronic diseases, aided further by increasing patients being treated in ICUs and emergency departments.

These are the latest findings of Coherent Market Insights (Seattle, WA, USA), a market research and consulting firm.

However, the high possibility of infections transmitted through blood gas analyzers that are affected by patient-acquired infections such as blood-borne pathogens during testing procedures is likely to hamper the market growth. Additionally, blood gas analyzers are difficult to use and require trained personnel. Moreover, the collection of arterial blood is more difficult than venous or capillary blood sample and can be more painful to the patient or even dangerous in case incorrect procedure is followed. All these factors are expected to negatively impact the growth of the global blood gas analyzers market.

The market players are focusing on developing cost-effective, easy-to-use blood gas analyzers that deliver reliable and fast results. They are also focusing on developing portable blood gas analyzers in order to increase the usability and comfort of the devices.

Geographically, the North American blood gas analyzers market is expected to generate significant revenue during the forecast period, driven by the rising lifestyle-induced diseases and high emergency department visits. The blood gas analyzers market in Asia-Pacific is expected to register the highest growth during the forecast period due to the region’s increasing patient population.

Related Links:
Coherent Market Insights


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.